omniture

Renhuang Pharmaceuticals Exhibits its All-Natural Products at the 108th China Import and Export Fair

2010-11-23 18:54 1299

HARBIN, China, Nov. 23, 2010 /PRNewswire-Asia-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (NYSE Amex: CBP) ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that the Company successfully exhibited its unique portfolio of natural products at the 108th China Import and Export Fair ("the 108th Canton Fair") recently held in Guangzhou, China.

A total of 199,266 overseas buyers from 208 countries and regions around the world attended the 108th Canton Fair. The numbers of buyers among the top five countries are: Hong Kong SAR with 26,691, the United States with 11,650, Taiwan Province with 8686, Iran with 6,786, and Russia with 6,549 buyers. Renhuang exhibited its leading range of all-natural Siberian Ginseng products, which have proven benefits to alleviate symptoms of depression with none of the side effects associated with harsh chemical-based treatments. The Company also showcased its recently introduced Ginseng and Deer Antler Extract, which has proven benefits in treating kidney and blood disorders, improving physical recovery, promoting longevity and improving male physical vitality.  At the 108th Canton Fair, Renhuang attracted over 1,000 foreign and domestic visitors at its booth, and signed an aggregate of over RMB three million (or $0.45 million) in letters of intent from more than 10 prospective distributors.

"Our products exhibited at the 108th Canton Fair received an overwhelming response and interest from both domestic and international buyers," said Mr. Shaoming Li, Chairman and Chief Executive Officer of Renhuang.  "Our participation at these events and fairs comprises an important component of our overall marketing and growth strategy.  We continue to focus on spreading awareness and education of our distinguished product offering and these fairs present an outstanding opportunity to showcase our products to an international audience. We anticipate continued sales growth from China and will also focus on expanding into export opportunities."

About China Import and Export Fair

China Import and Export Fair, also known as the Canton Fair, is held twice a year in the spring and autumn since its inauguration in 1957. It is China's largest trade fair with the highest attendance. Preserving its tradition, the Canton Fair is a comprehensive and multi-functional event of international importance. The Canton Fair is co-hosted by the Ministry of Commerce of China and the People's Government of Guangdong Province to help foster the development of China's foreign trade and exchange with the rest of the world. To learn more, please visit http://www.cantonfair.org.cn/en/index.asp.

ABOUT RENHUANG PHARMACEUTICALS, INC.

Renhuang Pharmaceuticals, Inc. is engaged in the research, development, manufacturing, and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines ("TCM"), in the People's Republic of China. All of the Company's products are produced at its three GMP-certified production facilities in Ah City, Dongfanghong and Qingyang. The Company distributes its botanical anti-depression and nerve-regulation products, biopharmaceutical products, and botanical antibiotic and OTC TCMs through its network of over 3,000 distributors and over 70 sales centers across 24 provinces in China. Company Website: www.renhuang.com.

Safe Harbor Statement

This press release contains certain statements that may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are based upon management's beliefs, assumptions and expectations of the Company's future operations and economic performance, taking into account the information currently available to management. These statements are not statements of historical fact. Forward-looking statements involve risks and uncertainties, some of which are not currently known that may cause actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial condition expressed or implied in any forward-looking statements. These forward-looking statements are based on current plans and expectations and are subject to a number of uncertainties including, but not limited to, the Company's ability to manage expansion of its operations effectively, perceived benefits from participation at the 108th Canton Fair, and other factors detailed in the Company's annual report on Form 10-K and other filings with the Securities and Exchange Commission.  The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented herein.

Company Contact:


Renhuang Pharmaceuticals, Inc.


Ms. Portia Tan, IR Contact        


Tel: +86-451-8260-2162


Email: ir@renhuang.com      




CCG Investor Relations:


Mr. Mark Collinson, Partner


Phone: +1-310-954-1343 (Los Angeles)


Email: mark.collinson@ccgir.com


Website: www.ccgirasia.com




Mr. Crocker Coulson, President


Phone: +1-646-213-1915 (New York)


Email: crocker.coulson@ccgir.com



Source: Renhuang Pharmaceuticals, Inc.
Related Stocks:
AMEX:CBP
collection